Correlations of the expression of fibroblast growth factor-2, vascular endothelial growth factor, and their receptors with angiogenesis in synovial tissues from patients with internal derangement of the temporomandibular joint

Journal of Dental Research

Volumn 82, Issue 4, 2003, Pages 272-277

  Sato, J ^a   Segami, N ^a   Yoshitake, Y ^a   Nishikawa, K ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; FGF 2; Synovial tissue; TMJ; VEGF

Indexed keywords

CD34 ANTIGEN; ENDOTHELIAL CELL GROWTH FACTOR; FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; LYMPHOKINE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; DISLOCATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; RISK; STATISTICAL MODEL; SYNOVITIS; SYNOVIUM; TEMPOROMANDIBULAR JOINT DISORDER; VASCULARIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CASE-CONTROL STUDIES; DISLOCATIONS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LOGISTIC MODELS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; ODDS RATIO; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; STATISTICS, NONPARAMETRIC; SYNOVIAL MEMBRANE; SYNOVITIS; TEMPOROMANDIBULAR JOINT DISORDERS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037393953     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910308200406     Document Type: Article

References (28)

1. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, et al. (1995). Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461.
2. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR (1992). Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220.
3. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Ket B, et al. (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97:469-476.
4. Burke D, Wilkes D, Blundell TL, Malcolm S (1998). Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 23:59-62.
5. Carmeliet P, Jain RK (2000). Angiogenesis in cancer and other diseases. Nature 407:249-257.
6. Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, et al. (1999). Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-FLt-1 and VEGF-R2-FLk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J Pathol 188:369-377.
7. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, et al. (1990). Cloning and expression of two distinct high-affinity receptors cross reacting with acidic and basic fibroblast growth factors. EMBO J 9:2685-2692.
8. Folkman J, Watson K, Ingber D, Hanahan D (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61.
9. Fu K, Ma X, Zhang Z, Pang X, Chen W (1995). Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9:131-137.
10. Galzie Z, Kinsella AR, Smith JA (1997). Fibroblast growth factors and their receptors. Biochem Cell Biol 75:669-685.
11. Gynther GW, Holmlund AB, Reinholt FP (1994). Synovitis in internal derangement of the temporomandibular joint: correlation between arthroscopic and histologic findings. J Oral Maxillofac Surg 52:913-917.
12. Hsu SM, Raine L, Fanger H (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
13. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD (1997). Expression of vascular endothelial growth factor in synovial fibroblast is induced by hypoxia and interleukin 1 beta. J Rheumatol 24:1253-1259.
14. Jin KL, Mao XO, Greenberg DA (2000). Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 97:10242-10247.
15. Koch AE (1998). Angiogenesis: implication of rheumatoid arthritis. Arthritis Rheum 41:951-962.
16. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. (1994). Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. Am J Immunol 152:4149-4156.
17. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami KI (1998). Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 56:192-198.
18. Matsuzaki K, Yoshitake Y, Matsuo Y, Sasaki H, Nishikawa K (1989). Monoclonal antibodies against heparin-binding growth factor/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 86:9911-9915.
19. Merrill RG, Yih WY, Langan MJ (1990). A histologic evaluation of the accuracy of TMJ diagnostic arthroscopy. Oral Surg 70:393-398.
20. Ohta T, Yamamoto M, Numata M, Iseki S, Tsukioka Y, Miyashita T, et al. (1995). Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas. Br J Cancer 72:824-831.
21. Pufe T, Petersen W, Tillmann B, Mentlein R (2001). Splice variants VEGF 121 and VEGF 165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J Rheumatol 28:1482-1485.
22. Sato J, Segami N, Suzuki T, Kaneyama K, Yoshitake Y, Nishikawa K (2002). The expression of vascular endothelial growth factor in synovial tissues in patients with internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:251-256.
23. Schulze-Osthoff K, Risau W, Vollmer E, Sorg C (1990). In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137:85-92.
24. Segami N, Kaneyama K, Tsurusako S, Suzuki T (1999). Arthroscopic eminoplasty for habitual dislocation of the temporomandibular joint: preliminary study. J Craniomaxillofac Surg 27:390-397.
25. Suzuki T, Segami N, Kaneyama K, Nishimura M, Nojima T (1999). Specific expression of interleukin-1beta in temporomandibular joints with internal derangement: correlation with clinical findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:413-417.
26. Szebenyi G, Fallon JF (1999). Fibroblast growth factor as multifunctional signaling factors. Int Rev Cytol 185:45-106.
27. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R (1998). Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:135-141.
28. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409.